HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dunne, B Articles by Griffin, M Search for Related Content PubMed PubMed Citation Articles by Dunne, B Articles by Griffin, M Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CIS-DIAMINEDICHLOROPLATINUM FLUOROURACIL PLATINUM COMPOUNDS Medline Plus Health Information Esophageal Cancer

A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy

¹ Department of Histopathology, St James's Hospital, Dublin 8, Ireland
² Department of Surgery, St James's Hospital
³ Department of Community Health and Statistics, Trinity College Dublin, Ireland

Dr Griffin Aims—To measure residual tumour in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy, to correlate specific pathological variables with survival, and to describe morphological changes in tumour and non-neoplastic tissue resulting from preoperative treatment.

Methods—Resection specimens from 47 cases of oesophageal adenocarcinoma treated with preoperative 5-fluorouracil/cisplatin and radiotherapy were reviewed. Residual tumour was assessed in terms of tumour regression grade (TRG), pTNM stage, lymphovascular space invasion, and resection margin involvement. Survival analysis was performed using the Kaplan-Meier method and log rank test. Cox's proportional hazard model was used for multivariate analysis.

Results—A complete pathological response (TRG1) was present in eight cases. The absence of residual tumour was confirmed by negative immunohistochemical staining for MNF116. Tumour corresponding to TRG2 was present in five cases, to TRG3 in nine, to TRG4 in 22, and to TRG5 in three. By multivariate analysis, pN0 status (n = 35) had a positive effect on survival (p = 0.04) and TRG had no significant effect on survival (p = 0.06). Patients with pN0 tumours had a median survival of 48 months versus eight months for those with pN1 tumours (log rank test, p < 0.0001). We found that giant fibroblasts were discernible from single large residual tumour cells on haematoxylin and eosin alone.

Conclusion—Response to preoperative chemoradiotherapy in oesophageal adenocarcinoma is variable. Although there are as yet no reliable predictors of response to treatment, patients who are identified at diagnosis as having negative loco-regional lymph nodes should benefit considerably from this treatment approach.

Key Words: oesophageal adenocarcinoma • preoperative chemoradiotherapy • tumour regression • prognosis

This article has been cited by other articles:

				C. J R Stewart and S. Hillery Mucosal endocrine cell micronests and single endocrine cells following neo-adjuvant therapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction J. Clin. Pathol., November 1, 2007; 60(11): 1284 - 1289. [Abstract] [Full Text] [PDF]

				N. P. Rizk, E. Venkatraman, M. S. Bains, B. Park, R. Flores, L. Tang, D. H. Ilson, B. D. Minsky, and V. W. Rusch American Joint Committee on Cancer Staging System Does Not Accurately Predict Survival in Patients Receiving Multimodality Therapy for Esophageal Adenocarcinoma J. Clin. Oncol., February 10, 2007; 25(5): 507 - 512. [Abstract] [Full Text] [PDF]

				S K Suvarna and T J Stephenson A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy J. Clin. Pathol., September 1, 2002; 55(9): 718 - 718. [Full Text] [PDF]